Description

PNC‑27
A synthetic peptide designed to selectively target and eliminate cancer cells by disrupting their protective mechanisms.
Binds to the HDM-2 receptor on tumor cell membranes, inducing apoptosis specifically in malignant cells
Exhibits a tumor-penetrating helicity that enables it to disrupt cancer cell membrane integrity
Demonstrates high selectivity—minimizes damage to healthy cells
Shown efficacy in melanoma, leukemia, breast, and colon cancer models
Ideal for research focused on targeted cancer therapies, precision oncology, and novel anti-tumor agents